tanezumab Archives -

tanezumab

Any lingering hope that Pfizer may finally get a regulatory approval for its nerve growth factor (NGF) inhibitor

EU panel rejects Pfizer’s tanezumab for osteoarthritis pain

https://pharmaphorum.com/news/eu-panel-rejects-pfizers-tanezumab-for-osteoarthritis-pain/

After more than a decade of fraught clinical development it looks like the end of the line for

Thumbs-down from FDA experts for Pfizer/Lilly’s painkiller tanezumab

https://pharmaphorum.com/news/fda-experts-give-thumbs-down-for-pfizer-lillys-painkiller-tanezumab/

After years in development, the FDA has started its review of Pfizer and Eli Lilly’s new painkiller tanezumab,

FDA starts review of Pfizer, Lilly’s non-opioid painkiller

https://pharmaphorum.com/news/fda-starts-review-of-pfizer-lillys-non-opioid-painkiller/

Results from a new study of Pfizer and Lilly’s non-opioid pain drug tanezumab have shown that it can

Pfizer/Lilly non-opioid pain drug shows more positive results

https://pharmaphorum.com/news/pfizer-lilly-non-opioid-pain-drug-shows-more-positive-results/

Pfizer and Eli Lilly have announced more positive results from a phase 3 study of their non-opioid pain

More positive results for Pfizer/Lilly’s non-opioid pain drug

https://pharmaphorum.com/news/more-positive-results-for-pfizer-lillys-non-opioid-pain-drug/

tanezumab